Experts say the Galleri blood test could be feasible to deliver at scale within the NHS, based on ongoing evaluation. Coverage focuses on the NHS-Galleri trial, which is assessing how well the blood test performs when used in a real health service setting rather than only in controlled studies. The trial also examines how the test might work alongside existing screening programmes. The aim is to determine whether combining approaches can help identify certain cancers earlier than current methods alone. Reporting highlights that the study is looking at practical deployment questions, including integration into routine care and how effectively the test contributes to cancer detection. While details such as specific results, timelines, and performance metrics are not provided in the supplied excerpts, the consistent theme across sources is that the experts believe large-scale implementation is being tested as part of the trial. The focus remains on establishing clinical and operational feasibility within the NHS framework.